Table 2.

Total number of hospitalizations and hospital days by pre-specified classification

	Total number of hospitalizations			Total number of hospital days
Reason for hospitalization	Placebo (n = 2327)	Dronedarone (n = 2301)	Log-rank test P value	Placebo (n = 2327)	Dronedarone (n = 2301)	Wilcoxon test P value
CV hospitalizations
AF and other supraventricular rhythm disorders	829	514	<0.0001	4637	3132	<0.0001
Worsening CHF, including pulmonary oedema or dysponea of cardiac origin	184	165	0.505	1511	1486	0.202
Acute coronary syndromea	113	71	0.01047	1188	816	0.038
Implantation of a pacemaker, implantable cardioverter defibrillator, or other cardiac device	83	65	NC	372	334	0.206
Stable angina pectoris or atypical chest pain	72	69	NC	533	402	0.611
TIA or stroke (except intracranial haemorrhage)	64	46	NC	1122	439	0.079
Transcutaneous coronary, cerebrovascular, or peripheral procedure	55	52	NC	165	168	0.718
CV surgery except cardiac transplantation	47	38	NC	436	332	0.519
Hypotension, hypertension; except syncope	40	30	NC	297	238	0.349
Major bleeding (requiring two or more units of blood or any intracranial haemorrhage)	33	41	NC	349	423	0.687
Syncope	33	32	NC	190	102	0.371
Atherosclerosis related (if not otherwise specified)	20	17	NC	269	199	0.693
Ventricular arrhythmia or non-fatal cardiac arrest	14	16	NC	120	91	0.820
Pulmonary embolism or deep vein thrombosis	6	15	NC	121	137	0.070
Ventricular extrasystoles	1	1	NC	13	3	0.994
Cardiac transplantation	1	0	NC	20	0	0.320
CV infection	0	5	NC	0	14	0.044
Other CV hospitalization	285	254	0.2842	1870	1524	0.240
Non-CV hospitalizations	715	676	0.480	6326	5901	0.703

NC, not calculable.

^aAcute coronary syndrome includes myocardial infarction or unstable angina.